Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 171 entries
Sorted by: Best Match Show Resources per page
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.

NAR cancer

Sohail M, Shkreta L, Toutant J, Rabea S, Babeu JP, Huard C, Coulombe-Huntington J, Delannoy A, Placet M, Geha S, Gendron FP, Boudreau F, Tyers M, Grierson DS, Chabot B.
PMID: 34316707
NAR Cancer. 2021 May 25;3(2):zcab019. doi: 10.1093/narcan/zcab019. eCollection 2021 Jun.

The elevated expression of the splicing regulator SRSF10 in metastatic colorectal cancer (CRC) stimulates the production of the pro-tumorigenic

Cite
Sohail M, Shkreta L, Toutant J, et al. A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. NAR Cancer. 2021;3(2):zcab019doi: 10.1093/narcan/zcab019.
Sohail, M., Shkreta, L., Toutant, J., Rabea, S., Babeu, J. P., Huard, C., Coulombe-Huntington, J., Delannoy, A., Placet, M., Geha, S., Gendron, F. P., Boudreau, F., Tyers, M., Grierson, D. S., & Chabot, B. (2021). A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. NAR cancer, 3(2), zcab019. https://doi.org/10.1093/narcan/zcab019
Sohail, Muhammad, et al. "A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells." NAR cancer vol. 3,2 (2021): zcab019. doi: https://doi.org/10.1093/narcan/zcab019
Sohail M, Shkreta L, Toutant J, Rabea S, Babeu JP, Huard C, Coulombe-Huntington J, Delannoy A, Placet M, Geha S, Gendron FP, Boudreau F, Tyers M, Grierson DS, Chabot B. A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. NAR Cancer. 2021 May 25;3(2):zcab019. doi: 10.1093/narcan/zcab019. eCollection 2021 Jun. PMID: 34316707; PMCID: PMC8210162.
Copy Download .nbib Format: NLM
TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA.

JCI insight

Platt JL, de Mattos Barbosa MG, Huynh D, Lefferts AR, Katta J, Kharas C, Freddolino P, Bassis CM, Wobus C, Geha R, Bram R, Nunez G, Kamada N, Cascalho M.
PMID: 34111031
JCI Insight. 2021 Jul 22;6(14). doi: 10.1172/jci.insight.148208.

TNFRSF13B encodes the transmembrane activator and CAML interactor (TACI) receptor, which drives plasma cell differentiation. Although TNFRSF13B supports host defense, dominant-negative TNFRSF13B alleles are common in humans and other species and only rarely associate with disease. We reasoned that...

Cite
Platt JL, de Mattos Barbosa MG, Huynh D, et al. TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA. JCI Insight. 2021;6(14)doi: 10.1172/jci.insight.148208.
Platt, J. L., de Mattos Barbosa, M. G., Huynh, D., Lefferts, A. R., Katta, J., Kharas, C., Freddolino, P., Bassis, C. M., Wobus, C., Geha, R., Bram, R., Nunez, G., Kamada, N., & Cascalho, M. (2021). TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA. JCI insight, 6(14), . https://doi.org/10.1172/jci.insight.148208
Platt, Jeffrey L, et al. "TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA." JCI insight vol. 6,14 (2021). doi: https://doi.org/10.1172/jci.insight.148208
Platt JL, de Mattos Barbosa MG, Huynh D, Lefferts AR, Katta J, Kharas C, Freddolino P, Bassis CM, Wobus C, Geha R, Bram R, Nunez G, Kamada N, Cascalho M. TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA. JCI Insight. 2021 Jul 22;6(14). doi: 10.1172/jci.insight.148208. PMID: 34111031; PMCID: PMC8410086.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Aug 07; doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, . https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. (2021). doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Aug 07; doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
Impalement injury of the perineum with an iron rod with a minimal injury: A near miss: A case report.

International journal of surgery case reports

Shrestha BM, Koirala DP, Shrestha S, Kharel S, Lamichane SR, Dahal GR.
PMID: 33607366
Int J Surg Case Rep. 2021 Mar;80:105645. doi: 10.1016/j.ijscr.2021.105645. Epub 2021 Feb 11.

INTRODUCTION AND IMPORTANCE: Penetrating perineal injury in children is uncommon. However, the injury is serious and life-threatening with significant morbidity and mortality.CASE PRESENTATION: We report an unusual case of a 13-year-old boy with an accidental perineal impalement injury by...

Cite
Shrestha BM, Koirala DP, Shrestha S, et al. Impalement injury of the perineum with an iron rod with a minimal injury: A near miss: A case report. Int J Surg Case Rep. 2021;80:105645doi: 10.1016/j.ijscr.2021.105645.
Shrestha, B. M., Koirala, D. P., Shrestha, S., Kharel, S., Lamichane, S. R., & Dahal, G. R. (2021). Impalement injury of the perineum with an iron rod with a minimal injury: A near miss: A case report. International journal of surgery case reports, 80105645. https://doi.org/10.1016/j.ijscr.2021.105645
Shrestha, Bibek Man, et al. "Impalement injury of the perineum with an iron rod with a minimal injury: A near miss: A case report." International journal of surgery case reports vol. 80 (2021): 105645. doi: https://doi.org/10.1016/j.ijscr.2021.105645
Shrestha BM, Koirala DP, Shrestha S, Kharel S, Lamichane SR, Dahal GR. Impalement injury of the perineum with an iron rod with a minimal injury: A near miss: A case report. Int J Surg Case Rep. 2021 Mar;80:105645. doi: 10.1016/j.ijscr.2021.105645. Epub 2021 Feb 11. PMID: 33607366; PMCID: PMC7900347.
Copy Download .nbib Format: NLM
Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis.

Expert opinion on drug safety

Castro CT, Gama RS, Pereira M, Oliveira MG, Dal-Pizzol TS, Barreto ML, Santos DB.
PMID: 34964403
Expert Opin Drug Saf. 2021 Dec 29; doi: 10.1080/14740338.2022.2020246. Epub 2021 Dec 29.

INTRODUCTION: A high number of women are exposed to acetaminophen during pregnancy worldwide. This drug safety during pregnancy regarding preterm birth, birth weight, and fetal development has not been well described. This study investigated the effect of acetaminophen use...

Cite
Castro CT, Gama RS, Pereira M, et al. Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis. Expert Opin Drug Saf. 2021;doi: 10.1080/14740338.2022.2020246.
Castro, C. T., Gama, R. S., Pereira, M., Oliveira, M. G., Dal-Pizzol, T. S., Barreto, M. L., & Santos, D. B. (2021). Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis. Expert opinion on drug safety, . https://doi.org/10.1080/14740338.2022.2020246
Castro, Caroline T, et al. "Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis." Expert opinion on drug safety vol. (2021). doi: https://doi.org/10.1080/14740338.2022.2020246
Castro CT, Gama RS, Pereira M, Oliveira MG, Dal-Pizzol TS, Barreto ML, Santos DB. Effect of acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis. Expert Opin Drug Saf. 2021 Dec 29; doi: 10.1080/14740338.2022.2020246. Epub 2021 Dec 29. PMID: 34964403.
Copy Download .nbib Format: NLM
Consensus Middle East and North Africa Registry on Inborn Errors of Immunity.

Journal of clinical immunology

Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J, Maródi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H.
PMID: 34052995
J Clin Immunol. 2021 Aug;41(6):1339-1351. doi: 10.1007/s10875-021-01053-z. Epub 2021 May 29.

BACKGROUND: Inborn errors of immunity (IEIs) are a heterogeneous group of genetic defects of immunity, which cause high rates of morbidity and mortality mainly among children due to infectious and non-infectious complications. The IEI burden has been critically underestimated...

Cite
Aghamohammadi A, Rezaei N, Yazdani R, et al. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021;41(6):1339-1351doi: 10.1007/s10875-021-01053-z.
Aghamohammadi, A., Rezaei, N., Yazdani, R., Delavari, S., Kutukculer, N., Topyildiz, E., Ozen, A., Baris, S., Karakoc-Aydiner, E., Kilic, S. S., Kose, H., Gulez, N., Genel, F., Reisli, I., Djenouhat, K., Tahiat, A., Boukari, R., Ladj, S., Belbouab, R., Ferhani, Y., Belaid, B., Djidjik, R., Kechout, N., Attal, N., Saidani, K., Barbouche, R., Bousfiha, A., Sobh, A., Rizk, R., Elnagdy, M. H., Al-Ahmed, M., Al-Tamemi, S., Nasrullayeva, G., Adeli, M., Al-Nesf, M., Hassen, A., Mehawej, C., Irani, C., Megarbane, A., Quinn, J., Maródi, L., Modell, V., Modell, F., Al-Herz, W., Geha, R. S., & Abolhassani, H. (2021). Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. Journal of clinical immunology, 41(6), 1339-1351. https://doi.org/10.1007/s10875-021-01053-z
Aghamohammadi, Asghar, et al. "Consensus Middle East and North Africa Registry on Inborn Errors of Immunity." Journal of clinical immunology vol. 41,6 (2021): 1339-1351. doi: https://doi.org/10.1007/s10875-021-01053-z
Aghamohammadi A, Rezaei N, Yazdani R, Delavari S, Kutukculer N, Topyildiz E, Ozen A, Baris S, Karakoc-Aydiner E, Kilic SS, Kose H, Gulez N, Genel F, Reisli I, Djenouhat K, Tahiat A, Boukari R, Ladj S, Belbouab R, Ferhani Y, Belaid B, Djidjik R, Kechout N, Attal N, Saidani K, Barbouche R, Bousfiha A, Sobh A, Rizk R, Elnagdy MH, Al-Ahmed M, Al-Tamemi S, Nasrullayeva G, Adeli M, Al-Nesf M, Hassen A, Mehawej C, Irani C, Megarbane A, Quinn J, Maródi L, Modell V, Modell F, Al-Herz W, Geha RS, Abolhassani H. Consensus Middle East and North Africa Registry on Inborn Errors of Immunity. J Clin Immunol. 2021 Aug;41(6):1339-1351. doi: 10.1007/s10875-021-01053-z. Epub 2021 May 29. PMID: 34052995; PMCID: PMC8310844.
Copy Download .nbib Format: NLM
Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations.

Journal of clinical immunology

Giardino G, Sharapova SO, Ciznar P, Dhalla F, Maragliano L, Radha Rama Devi A, Islamoglu C, Ikinciogullari A, Haskologlu S, Dogu F, Hanna-Wakim R, Dbaibo G, Chou J, Cirillo E, Borzacchiello C, Kreins AY, Worth A, Rota IA, Marques JG, Sayitoglu M, Firtina S, Mahdi M, Geha R, Neven B, Sousa AE, Benfenati F, Hollander GA, Davies EG, Pignata C.
PMID: 33464451
J Clin Immunol. 2021 May;41(4):756-768. doi: 10.1007/s10875-021-00967-y. Epub 2021 Jan 19.

Human nude SCID is a rare autosomal recessive inborn error of immunity (IEI) characterized by congenital athymia, alopecia, and nail dystrophy. Few cases have been reported to date. However, the recent introduction of newborn screening for IEIs and high-throughput...

Cite
Giardino G, Sharapova SO, Ciznar P, et al. Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations. J Clin Immunol. 2021;41(4):756-768doi: 10.1007/s10875-021-00967-y.
Giardino, G., Sharapova, S. O., Ciznar, P., Dhalla, F., Maragliano, L., Radha Rama Devi, A., Islamoglu, C., Ikinciogullari, A., Haskologlu, S., Dogu, F., Hanna-Wakim, R., Dbaibo, G., Chou, J., Cirillo, E., Borzacchiello, C., Kreins, A. Y., Worth, A., Rota, I. A., Marques, J. G., Sayitoglu, M., Firtina, S., Mahdi, M., Geha, R., Neven, B., Sousa, A. E., Benfenati, F., Hollander, G. A., Davies, E. G., & Pignata, C. (2021). Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations. Journal of clinical immunology, 41(4), 756-768. https://doi.org/10.1007/s10875-021-00967-y
Giardino, Giuliana, et al. "Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations." Journal of clinical immunology vol. 41,4 (2021): 756-768. doi: https://doi.org/10.1007/s10875-021-00967-y
Giardino G, Sharapova SO, Ciznar P, Dhalla F, Maragliano L, Radha Rama Devi A, Islamoglu C, Ikinciogullari A, Haskologlu S, Dogu F, Hanna-Wakim R, Dbaibo G, Chou J, Cirillo E, Borzacchiello C, Kreins AY, Worth A, Rota IA, Marques JG, Sayitoglu M, Firtina S, Mahdi M, Geha R, Neven B, Sousa AE, Benfenati F, Hollander GA, Davies EG, Pignata C. Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations. J Clin Immunol. 2021 May;41(4):756-768. doi: 10.1007/s10875-021-00967-y. Epub 2021 Jan 19. PMID: 33464451; PMCID: PMC8068652.
Copy Download .nbib Format: NLM
Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?.

Transplantation direct

Goss MB, Galván NTN, Geha JD, Moreno NF, Cotton RT, Rana A, O'Mahony CA, Goss JA.
PMID: 33521250
Transplant Direct. 2021 Jan 26;7(2):e661. doi: 10.1097/TXD.0000000000001103. eCollection 2021 Feb.

BACKGROUND: Successful liver transplantation is dependent on restoration of hepatic arterial (HA) flow. Although uncommon, some native recipient HAs are not suitable or inadequate for anastomosis, thereby necessitating extra-anatomic HA reconstruction. Splenic artery transposition (SAT) is 1 method of...

Cite
Goss MB, Galván NTN, Geha JD, et al. Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?. Transplant Direct. 2021;7(2):e661doi: 10.1097/TXD.0000000000001103.
Goss, M. B., Galván, N. T. N., Geha, J. D., Moreno, N. F., Cotton, R. T., Rana, A., O'Mahony, C. A., & Goss, J. A. (2021). Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?. Transplantation direct, 7(2), e661. https://doi.org/10.1097/TXD.0000000000001103
Goss, Matthew B, et al. "Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?." Transplantation direct vol. 7,2 (2021): e661. doi: https://doi.org/10.1097/TXD.0000000000001103
Goss MB, Galván NTN, Geha JD, Moreno NF, Cotton RT, Rana A, O'Mahony CA, Goss JA. Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?. Transplant Direct. 2021 Jan 26;7(2):e661. doi: 10.1097/TXD.0000000000001103. eCollection 2021 Feb. PMID: 33521250; PMCID: PMC7838009.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;36(12):2874-2887doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, 36(12), 2874-2887. https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. 36,12 (2021): 2874-2887. doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ.

Organic & biomolecular chemistry

Ravindran J, Yadhukrishnan VO, Asha RS, Lankalapalli RS.
PMID: 32409804
Org Biomol Chem. 2020 May 27;18(20):3927-3937. doi: 10.1039/d0ob00721h.

Multicomponent reactions (MCRs) using dienaminodioate with post-benzylic oxidative transformation mediated by DDQ that afforded a diverse array of products are described. An unprecedented rearrangement of 1,2-dihydropyridines (1,2-DHPs), 3CR products, to 2-pyridones in good yields with a broad substrate scope...

Cite
Ravindran J, Yadhukrishnan VO, Asha RS, et al. Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ. Org Biomol Chem. 2020;18(20):3927-3937doi: 10.1039/d0ob00721h.
Ravindran, J., Yadhukrishnan, V. O., Asha, R. S., & Lankalapalli, R. S. (2020). Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ. Organic & biomolecular chemistry, 18(20), 3927-3937. https://doi.org/10.1039/d0ob00721h
Ravindran, Jaice, et al. "Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ." Organic & biomolecular chemistry vol. 18,20 (2020): 3927-3937. doi: https://doi.org/10.1039/d0ob00721h
Ravindran J, Yadhukrishnan VO, Asha RS, Lankalapalli RS. Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ. Org Biomol Chem. 2020 May 27;18(20):3927-3937. doi: 10.1039/d0ob00721h. PMID: 32409804.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;36(12):2874-2887doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, 36(12), 2874-2887. https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. 36,12 (2021): 2874-2887. doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.

Frontiers in oncology

ElHarouni D, Yassin D, Ali N, Gohar S, Zaky I, Adwan H, Sidhom I.
PMID: 30533396
Front Oncol. 2018 Nov 23;8:541. doi: 10.3389/fonc.2018.00541. eCollection 2018.

No abstract available.

Cite
ElHarouni D, Yassin D, Ali N, et al. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia. Front Oncol. 2018;8:541doi: 10.3389/fonc.2018.00541.
ElHarouni, D., Yassin, D., Ali, N., Gohar, S., Zaky, I., Adwan, H., & Sidhom, I. (2018). A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia. Frontiers in oncology, 8541. https://doi.org/10.3389/fonc.2018.00541
ElHarouni, Dina, et al. "A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia." Frontiers in oncology vol. 8 (2018): 541. doi: https://doi.org/10.3389/fonc.2018.00541
ElHarouni D, Yassin D, Ali N, Gohar S, Zaky I, Adwan H, Sidhom I. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia. Front Oncol. 2018 Nov 23;8:541. doi: 10.3389/fonc.2018.00541. eCollection 2018. PMID: 30533396; PMCID: PMC6266501.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 171 entries